Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies
Related Experiment Video
Updated: Oct 12, 2025

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
Wissam H Faour1, Ali Choaib2, Elio Issa2
1Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, P.O. Box 36, Byblos, Lebanon. wissam.faour@lau.edu.lb.
Abstract:
The COVID-19 pandemic created a worldwide debilitating health crisis with the entire humanity suffering from the deleterious effects associated with the high infectivity and mortality rates. While significant evidence is currently available online and targets various aspects of the disease, both inflammatory and noninflammatory kidney manifestations secondary to COVID-19 infection are still largely underrepresented. In this review, we summarized current knowledge about COVID-19-related kidney manifestations, their pathologic mechanisms as well as various pharmacotherapies used to treat patients with COVID-19. We also shed light on the effect of these medications on kidney functions that can further enhance renal damage secondary to the illness.
Insights
This review details COVID-19's impact on kidney health, covering inflammatory and noninflammatory kidney issues. It examines disease mechanisms and treatments, highlighting how medications may worsen renal damage.
Area of Science:
- Nephrology
- Infectious Diseases
- Pharmacology
Background:
- The COVID-19 pandemic caused a global health crisis with significant mortality.
- Kidney manifestations of COVID-19, both inflammatory and noninflammatory, are underrepresented in current literature.
- Understanding these kidney issues is crucial for comprehensive patient care.
Purpose of the Study:
- To review current knowledge on COVID-19-related kidney manifestations.
- To explore the underlying pathologic mechanisms of these renal complications.
- To analyze the impact of COVID-19 pharmacotherapies on kidney function.
Main Methods:
- Systematic literature review of COVID-19 and kidney disease.
- Analysis of pathological mechanisms linking SARS-CoV-2 infection to renal damage.
- Evaluation of drug effects on kidney function in COVID-19 patients.
Main Results:
- COVID-19 can cause diverse kidney problems, including acute kidney injury and glomerulopathy.
- Viral infection and systemic inflammation contribute to kidney damage.
- Certain medications used for COVID-19 may exacerbate pre-existing or induced renal impairment.
Conclusions:
- COVID-19 poses a significant threat to kidney health through various mechanisms.
- Pharmacotherapies for COVID-19 require careful consideration regarding their nephrotoxic potential.
- Further research is needed to optimize treatment strategies and protect kidney function in COVID-19 patients.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury II: Pathophysiology
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury I: Introduction

